This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

GE Healthcare And Real Time Medical Partner To Further Empower Pathologists, Helping Improve Speed And Accuracy Of Diagnosis

TORONTO, June 3, 2014 /PRNewswire/ -- GE Healthcare just announced a strategic partnership with Real Time Medical, an award-winning developer of workflow management software solutions. The agreement will allow GE Healthcare to offer a streamlined workflow that seamlessly connects pathologists and other clinicians, facilitating collaboration to help enhance accuracy and speed of diagnosis.

Empowering pathologists with information technology to remove manual processes and delays, GE Healthcare now offers Omnyx IDP, a scanner and software solution to allow pathologists to digitally view and share slide images with colleagues across locations. The addition of Real Time Medical's DiaShare workflow management platform will further speed up the process, connecting pathologists in real time by creating a workflow, which automatically alerts colleagues to new cases to review, tracks progress and allows pathologists to report results.

By offering Omnyx IDP and DiaShare as a combined solution, GE Healthcare is now advancing its digital pathology capabilities by connecting networks and delivering smooth sub-specialty workflows in anatomic pathology. Pathologists can now share image data and collaborate with peers in near real time to improve decision making and facilitate learning.

Omnyx CEO Mamar Gelaye said: "There has been huge investment in information technology in most areas of the hospital to improve clinical outcomes and productivity, but little has been done to empower the pathologist. For a long time, pathologists have been disconnected – from each other and from other clinicians and patient data.

"This solution empowers decision making for pathologists, enabling them to collaborate more easily and quickly with their colleagues. Today, Omnyx helps pathologists be better connected—they still have to alert colleagues manually to cases to review in the system. Now, by combining our Omnyx solution with Real Time Medical's DiaShare , platform we are able to go one step further. Our combined solutions address important needs to further streamline the pathology workflow which will improve access to subspecialty expertise within a single, intuitive workflow."

Ian Maynard, CEO and Co-Founder of Real Time Medical, said: "Our DiaShare workflow management platform is a multi-disciplinary digital imaging solution that was designed to drive operational efficiencies, enhance productivity, and improve quality of care. We are excited by the opportunity to help transform ways of working for pathologists and to be working with GE Healthcare and Omnyx as strategic partners."

Omnyx IDP solutions are offered for primary diagnostic use in Europe and Canada, and for limited clinical use as well as research use in the United States.

Omnyx is a trademark of Omnyx, LLC.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs